These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17716341)

  • 1. Applicability of cost-effectiveness analysis to management of chronic hepatitis B.
    Dan YY; Lim SG
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1357-9. PubMed ID: 17716341
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.
    Sullivan SD; Veenstra DL; Chen PJ; Chang TT; Chuang WL; Tsai C; Patel K
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1494-9. PubMed ID: 17716353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and cost-utility of the treatment of chronic hepatitis B with peginterferon alfa-2a, interferon alfa, and lamivudine in Lithuania.
    Vanagas G; Padaiga Z; Mickevičienė A
    Medicina (Kaunas); 2010; 46(12):835-42. PubMed ID: 21532288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom.
    Veenstra DL; Sullivan SD; Dusheiko GM; Jacobs M; Aledort JE; Lewis G; Patel KK
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):631-8. PubMed ID: 17625431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan.
    Veenstra DL; Sullivan SD; Lai MY; Lee CM; Tsai CM; Patel KK
    Value Health; 2008; 11(2):131-8. PubMed ID: 18380625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore.
    Lacey LF; Gane E
    J Viral Hepat; 2007 Nov; 14(11):751-66. PubMed ID: 17927611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness in hepatitis B.
    Weitzman G; Jacobson I
    Ann Intern Med; 2005 Nov; 143(10):757-8; author reply 758-9. PubMed ID: 16287803
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States.
    Brooks EA; Lacey LF; Payne SL; Miller DW
    Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis B with interferon and combination therapy.
    Cooksley WG
    Clin Liver Dis; 2004 May; 8(2):353-70. PubMed ID: 15481344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea].
    Kim BK; Kwon SY; Lee CH; Choe WH; Choi HM; Koo HW
    Korean J Hepatol; 2009 Mar; 15(1):25-41. PubMed ID: 19346783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of alternative therapeutic strategies for the management of chronic hepatitis B in Poland.
    Orlewska E
    Value Health; 2002; 5(5):405-21. PubMed ID: 12201858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Antiviral regimens for chronic hepatitis B virus infection.
    Ann Intern Med; 2005 May; 142(10):I39. PubMed ID: 15897528
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis B].
    Lengyel G; Fehér J
    Orv Hetil; 2004 Sep; 145(36):1861-3. PubMed ID: 15508405
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation of treatments for chronic hepatitis B.
    Wiens A; Lenzi L; Venson R; Pedroso ML; Correr CJ; Pontarolo R
    Braz J Infect Dis; 2013; 17(4):418-26. PubMed ID: 23849851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peginterferon and lamivudine for hepatitis B.
    Assy NN; Hussein O
    N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
    Song K; Rajvanshi P
    N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16221792
    [No Abstract]   [Full Text] [Related]  

  • 17. The maze of treatments for hepatitis B.
    Lok AS
    N Engl J Med; 2005 Jun; 352(26):2743-6. PubMed ID: 15987924
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
    Orlent H
    N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16224825
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B.
    ter Borg MJ; Janssen HL
    Ann Intern Med; 2005 Sep; 143(5):391; author reply 391-2. PubMed ID: 16144900
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.
    Almeida AM; da Silva AL; Cherchiglia ML; Andrade EI; de Oliveira GL; Acurcio Fde A
    Value Health; 2011; 14(5 Suppl 1):S24-8. PubMed ID: 21839893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.